The European Society for Blood and Marrow Transplantation recommended using G-CSF for neutropenia, but only starting from 14 days post-CAR T infusion [58], and the National Comprehensive Cancer Network guidelines recommended against the routine use of G-CSF within 14 days after CAR-T infusion [59]. Here, CSF3 is linked to Decreased total neutrophil count.